Northeast Financial Consultants Inc - SEATTLE GENETICS INC ownership

SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 325 filers reported holding SEATTLE GENETICS INC in Q2 2019. The put-call ratio across all filers is 0.72 and the average weighting 0.3%.

Quarter-by-quarter ownership
Northeast Financial Consultants Inc ownership history of SEATTLE GENETICS INC
ValueSharesWeighting
Q3 2020$769,000
-23.6%
3,929
-33.7%
0.07%
-28.9%
Q2 2020$1,007,000
+123.8%
5,929
+52.0%
0.10%
+90.2%
Q1 2020$450,000
+0.9%
3,9000.0%0.05%
+27.5%
Q4 2019$446,000
+33.9%
3,9000.0%0.04%
+17.6%
Q3 2019$333,000
+23.3%
3,9000.0%0.03%
+21.4%
Q2 2019$270,000
-31.8%
3,900
-27.9%
0.03%
-36.4%
Q1 2019$396,0005,4100.04%
Other shareholders
SEATTLE GENETICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Baker Brothers Advisors 51,046,060$2,892,270,00023.68%
Lagoda Investment Management, L.P. 88,615$5,021,0008.38%
Matrix Capital Management Company, LP 3,141,852$178,017,0005.90%
Opus Point Partners Management, LLC 19,127$1,084,0002.39%
EMORY UNIVERSITY 41,539$2,354,0001.86%
Capital International Sarl 238,100$13,491,0001.62%
Rhenman & Partners Asset Management AB 242,198$13,723,0001.57%
CAPITAL GUARDIAN TRUST CO 1,341,050$75,984,0001.21%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 42,500$1,890,0001.17%
JGP Global Gestao de Recursos Ltda. 16,524$936,0001.14%
View complete list of SEATTLE GENETICS INC shareholders